LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

STERIS PLC

Chiusa

SettoreSettore sanitario

243.67 0.19

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

241.87

Massimo

244.67

Metriche Chiave

By Trading Economics

Entrata

-27M

146M

Vendite

110M

1.5B

P/E

Media del settore

39.363

51.198

EPS

2.74

Rendimento da dividendi

0.94

Margine di Profitto

9.892

Dipendenti

17,787

EBITDA

-158M

216M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+9.07% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

0.94%

2.40%

Utili prossimi

5 ago 2025

Prossima data del Dividendo

26 giu 2025

Prossima data del' Ex Dividendo

10 giu 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

912M

24B

Apertura precedente

243.48

Chiusura precedente

243.67

Notizie sul Sentiment di mercato

By Acuity

36%

64%

112 / 380 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Bearish Evidence

STERIS PLC Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

14 mag 2025, 20:30 UTC

Utili

Steris Sees FY Adj EPS $9.90-Adj EPS $10.15 >STE

14 mag 2025, 20:30 UTC

Utili

Steris 4Q Rev $1.5B >STE

14 mag 2025, 20:30 UTC

Utili

Steris 4Q Adj EPS $2.74 >STE

5 feb 2025, 21:35 UTC

Utili

Steris: Outlook Does Not Reflect Any Potential Impact From New Tariffs >STE

5 feb 2025, 21:34 UTC

Utili

Steris: FY25 Guidance Change Is Primarily Due to Currency >STE

5 feb 2025, 21:34 UTC

Utili

Steris Cuts FY25 Revenue View to Increase of About 6% From Prior View for 6.5%-7%>STE

5 feb 2025, 21:33 UTC

Utili

Steris 3Q EPS $1.75 >STE

5 feb 2025, 21:30 UTC

Utili

Steris Sees FY Adj EPS $9.05-Adj EPS $9.15 >STE

5 feb 2025, 21:30 UTC

Utili

Steris 3Q Rev $1.4B >STE

5 feb 2025, 21:30 UTC

Utili

Steris 3Q Adj EPS $2.32 >STE

6 nov 2024, 21:41 UTC

Utili

Steris Backs FY25 Revenue Up 6.5%-7.5% >STE

6 nov 2024, 21:40 UTC

Utili

Steris 2Q EPS $1.51 >STE

6 nov 2024, 21:30 UTC

Utili

Steris Sees FY Adj EPS $9.05-Adj EPS $9.25 >STE

6 nov 2024, 21:30 UTC

Utili

Steris 2Q Adj EPS $2.14 >STE

6 nov 2024, 21:30 UTC

Utili

Steris 2Q Rev $1.3B >STE

6 ago 2024, 20:36 UTC

Utili

Steris 1Q Adj EPS $2.03 >STE

6 ago 2024, 20:30 UTC

Utili

Steris 1Q Net $139.9M >STE

6 ago 2024, 20:30 UTC

Utili

Steris 1Q EPS $1.41 >STE

6 ago 2024, 20:30 UTC

Utili

Steris Sees FY Adj EPS $9.05-Adj EPS $9.25 >STE

Confronto tra pari

Modifica del prezzo

STERIS PLC Previsione

Obiettivo di Prezzo

By TipRanks

9.07% in crescita

Previsioni per 12 mesi

Media 265.83 USD  9.07%

Alto 280 USD

Basso 250 USD

Basato su 7 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per STERIS PLC - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

7 ratings

4

Acquista

3

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

225 / 226.35Supporto e resistenza

A breve termine

Bearish Evidence

A termine intermedio

Strong Bullish Evidence

A lungo termine

Strong Bullish Evidence

Sentiment

By Acuity

112 / 380 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo STERIS PLC

STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.